Articles in scientific journals and the media about bowel cancer screening

These articles link to evidence that supports the modelling and science behind the National Bowel Cancer Screening Program and its effectiveness.

Page last updated: 14 August 2020 (this page is generated automatically and reflects updates to other content within the website)


This article Compelling new data on the effectiveness of Australia's National Bowel Cancer Screening program: A model for best practice? studies the impact of the NBCSP by analysing data relating to the at-risk population in 2006–2008 and compares clinical outcomes in invitees and non-invitees up until December 2011.

Source: Asia-Pacific Journal of Clinical Oncology (Volume 12, Issue 1 March 2016 Pages 7–9)

This article Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study looks at a comprehensive natural history model and the most recent information about cancer treatment costs to estimate long-term benefits, costs, and harms of the NBCSP (two yearly immunochemical faecal occult blood testing screening at age 50–74 years) and evaluates the incremental effect of improved screening participation under different scenarios.

Source: The Lancet (Volume 2, No. 7, e331–e340, July 2017)

In this section